Navega Therapeutics 

Next generation pain management

OWNER

Fernando Aleman (See Profile)

Sector

Therapeutics

Stage

Prototyping, preclinical

Country

USA


We have developed gene therapy to target pain that is non-addictive, highly specific and long lasting

Huge market oportunity with non-dilutive funding available in the US.

3 Patents filed in 2016, 2017 and 2019

This information is confidential, do not share or copy.

Under evaluation at least till: 23rd May 2019

** PLEASE NOTE: THIS PROJECT IS NOT SEEKING CROWDFUNDING THROUGH CAPITAL CELL AND THEREFORE YOUR REVIEW WILL NOT EARN CREDITS **

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2019 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar